PreveCeutical Medical (PRVCF) Stock Chart & Stock Price History $0.03 +0.00 (+9.40%) As of 08/22/2025 03:53 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock PreveCeutical Medical Stock Price Performance The PreveCeutical Medical (PRVCF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 157.52%, with a year-to-date return of 58.15%. In the past month, the stock has increased 21.76%, reflecting recent market activity. As of the latest close, PreveCeutical Medical traded at $0.03 with a market cap of $16.61 million and volume of 42,750 shares. Five years ago, the stock traded at $0.04, representing a 31.37% decrease over that period. At the time, it had a market cap of $22.14 million and a volume of 701,038 shares. Receive PRVCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.93%1 Month Performance+21.76%3 Month Performance+12.36%Year-To-Date Performance+58.15%1 Year Performance+157.52%5 Year Performance-31.37% PRVCF Stock Chart for Monday, August, 25, 2025 PRVCF Chart by TradingView PreveCeutical Medical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.03$0.03+9.40%$0.03$0.0342,750 shs$16.61 million08/21/2025$0.03$0.03-5.00%$0.03$0.03143,912 shs$15.18 million08/20/2025$0.03$0.03+12.00%$0.03$0.0357,333 shs$15.98 million08/19/2025$0.03$0.03-13.79%$0.03$0.02287,960 shs$14.27 million08/18/2025$0.03$0.03+14.17%$0.03$0.02539,200 shs$16.55 million08/15/2025$0.02$0.03+3.25%$0.03$0.0233,000 shs$14.50 million08/14/2025$0.02$0.02-0.81%$0.03$0.0261,000 shs$14.04 million08/13/2025$0.03$0.02-0.80%$0.03$0.0237,920 shs$14.15 million08/12/2025$0.03$0.03$0.03$0.0393,500 shs$14.27 million08/11/2025$0.03$0.03-7.41%$0.03$0.0369,925 shs$14.27 million Get the Latest News and Ratings for PRVCF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$0.03$0.03+3.85%$0.03$0.032,000 shs$15.41 million08/07/2025$0.02$0.03+12.55%$0.03$0.0220,000 shs$14.84 million08/06/2025$0.02$0.02-5.71%$0.02$0.0245,000 shs$13.18 million08/05/2025$0.02$0.02+4.70%$0.02$0.021,500 shs$13.98 million08/04/2025$0.03$0.02-7.87%$0.02$0.0258,044 shs$13.35 million08/01/2025$0.02$0.03+17.59%$0.03$0.033,000 shs$14.50 million07/31/2025$0.02$0.02-1.37%$0.02$0.02600 shs$12.33 million07/30/2025$0.02$0.02-10.25%$0.02$0.021,200 shs$12.50 million07/29/2025$0.02$0.02+2.09%$0.02$0.0219,000 shs$13.92 million07/25/2025$0.02$0.02$0.02$0.028,000 shs$13.64 million07/24/2025$0.03$0.02-5.16%$0.02$0.028,000 shs$13.64 million Related Companies Rafael Stock Price Chart Verrica Pharmaceuticals Stock Price Chart PolyPid Stock Price Chart Karyopharm Therapeutics Stock Price Chart Fractyl Health Stock Price Chart NRx Pharmaceuticals Stock Price Chart Prelude Therapeutics Stock Price Chart Century Therapeutics Stock Price Chart Wellgistics Health Stock Price Chart Cumberland Pharmaceuticals Stock Price Chart Receive PRVCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PRVCF) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PreveCeutical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access